Complement Therapeutics doses first patient in Phase 1/Phase 2 Opti-GAIN [...]

Liver-metabolic disease is linked to increased heart failure risk in [...]

Mestag Therapeutics has raised $40 million and appointed two senior [...]

PolyPid is preparing to submit a New Drug Application for [...]

One-carbon Therapeutics has signed a collaboration with Tempus to generate [...]

From hospital haematology to leading early stage clinical trials, Margaret [...]

  The FDA has granted breakthrough therapy designation to Hemab [...]

A single photobiomodulation session reduced bacterial load in acute burn [...]

Munich-based Ethris GmbH is part of a seven-organisation European consortium [...]

As Rare Disease Day 2026 shines a spotlight on patients [...]